Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, read along with SEBI Circular no CIR/CFD/CMD 1/27/2019 dated February 8, 2019, Omkar Pharmachem has informed that it has enclosed the Annual Secretarial Compliance Report of the Company issued by Maulik Bhavsar & Associates, Practicing Company Secretaries for the financial year 2020-21.
The above information is a part of company’s filings submitted to BSE.